학술논문
Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI)
Document Type
Article
Author
Source
In Transfusion and Apheresis Science February 2021 60(1)
Subject
Language
ISSN
1473-0502